Skip to main content
    S

    STERIS plc (STE)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $262.05
    -2.27 (-0.86%)

    Market Cap: $25.67B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    STERIS plc (STE) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    STERIS reported revenue of $5.94B for the fiscal year ended Mar 31, 2026, up 8.7% from the year before. That year, net income was $785.10M with a net margin of 13.2%, operating cash flow was $1.34B and free cash flow was $972.40M. The quarter ended Sep 30, 2026 had revenue of $1.59B and net income of $214.10M.

    Revenue and Margins

    The operating margin was 18.6% in the fiscal year ended Mar 2026, the highest of the 10 years shown. Over the 9 years to Mar 2026, revenue grew from $2.61B, a compound annual rate of 9.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Mar 2026$5.94B+8.7%44.2%18.6%13.2%
    Mar 2025$5.46B+6.2%44.0%15.9%11.3%
    Mar 2024$5.14B+13.3%43.2%16.3%7.4%
    Mar 2023$4.54B+7.4%43.7%17.4%2.3%
    Mar 2022$4.22B+35.9%44.6%11.3%5.8%
    Mar 2021$3.11B+2.5%43.2%17.6%12.8%
    Mar 2020$3.03B+8.9%43.6%17.7%13.5%
    Mar 2019$2.78B+6.2%42.2%14.8%11.0%
    Mar 2018$2.62B+0.3%41.7%15.3%11.1%
    Mar 2017$2.61BN/A39.3%8.7%4.2%
    Annual, fiscal years ended Mar 2017 to Mar 2026

    Income Statement

    In the fiscal year ended Mar 2026, net income rose 27.4% from the year before. In the quarter ended Sep 2026, net income rose 11.2% from the same quarter a year earlier.

    Annual

    Line itemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Revenue$5.94B$5.46B$5.14B$4.54B$4.22B$3.11B$3.03B$2.78B$2.62B$2.61B
    Cost of revenue$3.31B$3.06B$2.92B$2.56B$2.34B$1.76B$1.71B$1.61B$1.53B$1.59B
    Gross profit$2.63B$2.40B$2.22B$1.98B$1.88B$1.34B$1.32B$1.17B$1.09B$1.03B
    Research and development$112.90M$107.60M$103.70M$98.48M$86.66M$66.33M$65.55M$63.04M$60.78M$59.40M
    Operating income$1.10B$866.60M$836.10M$791.10M$477.81M$548.37M$537.05M$411.02M$399.88M$226.21M
    Net income$785.10M$616.10M$380.10M$105.81M$242.87M$396.87M$407.86M$304.75M$291.62M$110.63M
    EBITDA$1.59B$1.36B$1.42B$1.35B$1.08B$773.95M$736.27M$639.97M$583.94M$417.31M
    Fiscal years ended Mar 2017 to Mar 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$1.59B$1.49B$1.59B$1.50B$1.46B$1.39B$1.48B$1.37B$1.33B$1.28B$1.42B$1.30B
    Gross profit$710.80M$684.20M$697.10M$655.50M$645.90M$628.00M$641.30M$610.30M$578.80M$572.40M$582.94M$560.03M
    Operating income$294.30M$285.80M$316.80M$273.20M$265.80M$246.00M$216.10M$245.30M$219.70M$185.50M$220.32M$226.47M
    Net income$214.10M$201.00M$220.30M$194.30M$192.50M$178.00M$146.10M$173.30M$151.20M$145.50M-$981.00K$140.94M
    Last 12 quarters

    Balance Sheet

    As of Mar 2026, total debt of $1.93B exceeded cash and equivalents by $1.49B.

    Annual

    Line itemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Total assets$10.74B$10.15B$11.06B$10.82B$11.42B$6.57B$5.44B$5.07B$5.20B$4.92B
    Current assets$2.39B$2.00B$2.87B$2.01B$1.88B$1.21B$1.22B$1.05B$989.66M$1.02B
    Cash and equivalents$439.60M$171.70M$207.02M$208.36M$348.32M$220.53M$319.58M$220.63M$201.53M$282.92M
    Total liabilities$3.54B$3.53B$4.75B$4.73B$4.88B$2.68B$2.02B$1.89B$1.98B$2.11B
    Short-term debt$118.90M$125.00M$85.94M$60.00M$142.88M$0$19.81M$0$74.70M$71.02M
    Long-term debt$1.81B$1.92B$3.12B$3.02B$2.95B$1.65B$1.15B$1.18B$1.32B$1.48B
    Shareholder equity$7.18B$6.60B$6.30B$6.08B$6.53B$3.88B$3.41B$3.18B$3.21B$2.81B
    Fiscal years ended Mar 2017 to Mar 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$10.71B$10.74B$10.74B$10.59B$10.41B$10.40B$10.15B$10.01B$10.24B$10.11B$11.06B$11.44B
    Total liabilities$3.44B$3.51B$3.54B$3.42B$3.39B$3.44B$3.53B$3.58B$3.63B$3.74B$4.75B$5.01B
    Cash and equivalents$531.10M$482.30M$439.60M$423.70M$319.20M$279.70M$171.70M$155.18M$172.19M$198.33M$207.02M$195.59M
    Shareholder equity$7.26B$7.21B$7.18B$7.15B$7.01B$6.96B$6.60B$6.42B$6.59B$6.35B$6.30B$6.42B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Mar 2026, free cash flow was 72.6% of operating cash flow. Dividends and share repurchases together came to 49.3% of it.

    Annual

    Line itemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Operating cash flow$1.34B$1.15B$973.30M$756.95M$684.81M$689.64M$590.56M$539.50M$457.63M$424.09M
    Capital expenditures$369.00M$370.10M$360.30M$361.97M$287.56M$239.26M$214.52M$189.72M$165.46M$172.90M
    Free cash flow$972.40M$778.00M$613.00M$394.98M$397.25M$450.38M$376.04M$349.79M$292.18M$251.19M
    Dividends paid$243.60M$222.40M$208.40M$185.76M$196.84M$140.41M$124.91M$114.08M$106.39M$103.11M
    Share repurchases$235.50M$211.30M$11.80M$308.56M$55.78M$14.65M$51.24M$81.49M$65.48M$97.51M
    Investing cash flow-$512.50M$388.80M-$887.40M-$383.33M-$666.56M-$1.15B-$319.74M-$213.22M-$203.83M-$104.25M
    Financing cash flow-$568.20M-$1.57B-$85.20M-$498.72M$115.83M$345.62M-$163.15M-$294.79M-$356.18M-$267.10M
    Fiscal years ended Mar 2017 to Mar 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$289.00M$367.10M$335.40M$298.20M$287.80M$420.00M$260.80M$332.80M$250.80M$303.70M$254.83M$291.24M
    Capital expenditures$76.10M$87.50M$90.20M$98.70M$86.50M$93.60M$70.90M$89.20M$101.90M$108.10M$91.47M$118.94M
    Free cash flow$212.90M$279.60M$245.20M$199.50M$201.30M$326.40M$189.90M$243.60M$148.90M$195.60M$163.36M$172.31M
    Last 12 quarters

    Frequently Asked Questions About STE

    What is STERIS's annual revenue?

    STERIS reported revenue of $5.94B for the fiscal year ended Mar 31, 2026.

    How fast is STERIS's revenue growing?

    Revenue was up 8.7% for the fiscal year ended Mar 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 9.4%.

    Is STERIS profitable?

    Yes. STERIS reported net income of $785.10M for the fiscal year ended Mar 31, 2026, with a net margin of 13.2%.

    How much free cash flow does STE generate?

    For the fiscal year ended Mar 31, 2026, operating cash flow of $1.34B minus capital expenditures of $369.00M produced free cash flow of $972.40M.

    How much debt does STERIS have?

    The balance sheet dated Mar 31, 2026 reported long-term debt of $1.81B, short-term debt of $118.90M and cash and equivalents of $439.60M.